Latest Breaking News On - Hybrid capture - Page 3 : comparemela.com

Industry News: QIAGEN and INOVIO expand collaboration to develop next-generation sequencing companion diagnostic for INOVIO’s VGX-3100 17 Mar 2021 QIAGEN and INOVIO Pharmaceuticals have announced an extension of their partnership with a new master collaboration agreement to develop liquid biopsy-based companion diagnostic products based on next-generation sequencing (NGS) technology to complement INOVIO’s therapies. The initial project in this expanded collaboration focuses on the co-development of a diagnostic test that identifies women who are most likely to benefit from clinical use of VGX-3100, INOVIO s immunotherapy to treat advanced cervical dysplasia associated with the human papillomavirus (HPV). QIAGEN’s bioinformatic expertise will further increase the predictive power of INOVIO’s preliminary biomarker signature –  and the assay will now be developed for use on the Illumina NextSeq™ 550Dx platform, the first development based on a partnership QIAGEN and Il

Jean pascal violaJ joseph kimWorld health organizationCorporate business developmentIndustry newsIllumina nextseqHybrid captureSenior vice presidentMolecular diagnostics business areaQiagen and inovio expand collaboration to develop next generation sequencing companion diagnostic for inovios vgx 3100Liquid biopsyஜீன் பாஸ்கல் வயலஜு ஜோசப் கிம்உலகம் ஆரோக்கியம் ஆர்கநைஸேஶந்பெருநிறுவன வணிக வளர்ச்சிதொழில் செய்தி